COMBINATION OF A GABA-A ALPHA 5 INVERSE AGONIST AND A NICOTINIC AGONIST
摘要
<p>The present invention relates to a combination of a nicotinic agonist and an inverse agonist of the GABAA α5 receptor subtype, and the use of the combination in treating neurodegenerative conditions such as Alzheimer's Disease.</p>
